Showing results (51-60 of 91) with videos related to
Sort By:
Pageof 10
BJOG : an International Journal of Obstetrics and Gynaecology|February 9, 2026
Modern Management of the Menopause: Are We Measuring What Matters?Joscelyn Gan, Michelle Steeper, Tim Hillard, et al.Human Reproduction Update|January 18, 2023
Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic reviewScott M Nelson, Susan R Davis, Sophia Kalantaridou, et al.Menopause International|September 28, 2013
A randomised controlled trial comparing the effects of micronized progesterone to medroxyprogesterone acetate on cardiovascular health, lipid metabolism and the coagulation cascade in women with premature ovarian insufficiency: study protocol and review of the literatureMonica Mittal, Michael Savvas, Roopen Arya, et al.Menopause (New York, N.Y.)|April 29, 2022
The effect of micronized progesterone and medroxyprogesterone acetate in combination with transdermal estradiol on hemostatic biomarkers in postmenopausal women diagnosed with POI and early menopause: a randomized trialMonica Mittal, Paradzai Chitongo, Prasanna Raj Supramaniam, et al.Post Reproductive Health|April 13, 2025
Feasibility of developing a new tool for assessing vaginal health in women with Genitourinary Syndrome of Menopause; The VAN studyPaula Briggs, Christopher Evans, Steven Lane, et al.The Journal of Obstetrics and Gynaecology Research|August 11, 2007
Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosisEmmanuel Kalu, Nazira Sumar, Theodoros Giannopoulos, et al.Climacteric : the Journal of the International Menopause Society|December 23, 2025
International Menopause Society (IMS) recommendations and key messages on women's midlife health and menopauseNick Panay, Anna Fenton, Haitham Hamoda, et al.Psychoneuroendocrinology|October 1, 2021
A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorderTorbjörn Bäckström, Karin Ekberg, Angelica Lindén Hirschberg, et al.Post Reproductive Health|April 21, 2022
Consensus-led recommendations supporting choice and personalisation of Hormone replacement therapy in menopause carePaula Briggs, Katie Barber, Kathie Cooke, et al.Maturitas|November 25, 2025
Estetrol for the treatment of moderate to severe vasomotor symptoms in postmenopausal women: The design of the E4COMFORT I and II trialsNick Panay, Tommaso Simoncini, Mélanie Taziaux, et al.Pageof 10